StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by Skrit37on May 04, 2020 2:41pm

170 Views

Post# 30984677

RE:Notice when he said

This quote is near the begining of the video

"right now we can detectect 10..infact 11,cancers from and single blood sample.. and we can do more then that"......he speciffically said 11...would like to know what the 11th is..he did not elaborate on it any further

Has this statement been made before? if not this is a big deal because the "Cancer" detection is growing into more and more as time goes on

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading